Interface Bio builds high-quality biological data sets to unlock the potential of AI-driven biology for drug discovery, focusing on inflammatory diseases such as inflammatory bowel disease, eczema, and rheumatoid arthritis.
investor of
Metrics
marketPRIVATE
msh_idBIO:INTERFACE
localeus
websitehttps://interface.bio
source_refb52a69f3-726f-46bf-a87d-ce85187d2eb9
products_or_servicesFull-stack pipeline for building high-quality biological data sets, AI-driven drug discovery platform
United States